000 | 01699 a2200481 4500 | ||
---|---|---|---|
005 | 20250512063937.0 | ||
264 | 0 | _c19871106 | |
008 | 198711s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm00393a022 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aManley, P W | |
245 | 0 | 0 |
_aThromboxane synthase inhibitors. Synthesis and pharmacological activity of (R)-, (S)-, and (+/-)-2,2-dimethyl-6-[2-(1H-imidazol-1-yl)-1-[[(4-methoxyphenyl)- methoxy]methyl]ethoxy]hexanoic acids. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cOct 1987 |
||
300 |
_a1812-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xblood |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCaproates _xchemical synthesis |
650 | 0 | 4 |
_aCollagen _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xchemical synthesis |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aProstaglandin Endoperoxides, Synthetic _xmetabolism |
650 | 0 | 4 | _aProstaglandin H2 |
650 | 0 | 4 |
_aProstaglandins H _xmetabolism |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 |
_aThromboxane B2 _xblood |
650 | 0 | 4 |
_aThromboxane-A Synthase _xantagonists & inhibitors |
700 | 1 | _aTuffin, D P | |
700 | 1 | _aAllanson, N M | |
700 | 1 | _aBuckle, P E | |
700 | 1 | _aLad, N | |
700 | 1 | _aLai, S M | |
700 | 1 | _aLunt, D O | |
700 | 1 | _aPorter, R A | |
700 | 1 | _aWade, P J | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 30 _gno. 10 _gp. 1812-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00393a022 _zAvailable from publisher's website |
999 |
_c3662058 _d3662058 |